Literature DB >> 1700785

Purification and structure of exendin-3, a new pancreatic secretagogue isolated from Heloderma horridum venom.

J Eng1, P C Andrews, W A Kleinman, L Singh, J P Raufman.   

Abstract

An amino-terminal histidyl structure (His1) is characteristic of most peptides in the glucagon superfamily. An assay for His1 peptides performed by amino-terminal amino acid sequencing was used to screen venom from the Gila monster lizard, Heloderma horridum. Two His1 peptides were identified: helospectin and a new His1 peptide that has been named exendin-3 to indicate that it is the third peptide to be found in an exocrine secretion of Heloderma lizards which has endocrine activity, the first two being helospectin (exendin-1) and helodermin (exendin-2). In the lot of H. horridum venom tested, exendin-3 was 5-10-fold more abundant in molar concentration than helospectin. The structure of exendin-3 was analyzed by amino acid sequencing and mass spectrometry. Exendin-3 is a 39-amino acid peptide with a mass of 4200. It contains a carboxyl-terminal amide and has a strong homology with secretin at its amino-terminal 12 amino acids. The complete structure of exendin-3 is His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala- Val-Arg - Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro- Ser- amide. It is 32 and 26% homologous with helospectin and helodermin, respectively. It has greatest homology with glucagon (48%) and human glucagon-like peptide-1 (50%). Exendin-3 (3 microM) stimulated increases in cellular cAMP and amylase release from dispersed guinea pig pancreatic acini.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

Authors:  J J Holst
Journal:  Diabetologia       Date:  2006-01-14       Impact factor: 10.122

3.  Exenatide can reduce glucose independent of islet hormones or gastric emptying.

Authors:  Viorica Ionut; Dan Zheng; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

4.  Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venom.

Authors:  Samuel D Robinson; Helena Safavi-Hemami; Shrinivasan Raghuraman; Julita S Imperial; Anthony T Papenfuss; Russell W Teichert; Anthony W Purcell; Baldomero M Olivera; Raymond S Norton
Journal:  J Proteomics       Date:  2014-11-15       Impact factor: 4.044

Review 5.  Physiology and emerging biochemistry of the glucagon-like peptide-1 receptor.

Authors:  Francis S Willard; Kyle W Sloop
Journal:  Exp Diabetes Res       Date:  2012-05-14

6.  Monotreme glucagon-like peptide-1 in venom and gut: one gene - two very different functions.

Authors:  Enkhjargal Tsend-Ayush; Chuan He; Mark A Myers; Sof Andrikopoulos; Nicole Wong; Patrick M Sexton; Denise Wootten; Briony E Forbes; Frank Grutzner
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

7.  RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling.

Authors:  Jaimini Cegla; Ben J Jones; James V Gardiner; David J Hodson; Thomas Marjot; Emma R McGlone; Tricia M Tan; Stephen R Bloom
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

Review 8.  Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.

Authors:  Anne-Cécile Van Baelen; Philippe Robin; Pascal Kessler; Arhamatoulaye Maïga; Nicolas Gilles; Denis Servent
Journal:  Front Mol Biosci       Date:  2022-02-07

Review 9.  Neglected Venomous Animals and Toxins: Underrated Biotechnological Tools in Drug Development.

Authors:  Guilherme Rabelo Coelho; Daiane Laise da Silva; Emidio Beraldo-Neto; Hugo Vigerelli; Laudiceia Alves de Oliveira; Juliana Mozer Sciani; Daniel Carvalho Pimenta
Journal:  Toxins (Basel)       Date:  2021-11-29       Impact factor: 4.546

10.  Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals.

Authors:  David M Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.